Stella M SungDr. Stella Sung is a life science/biotech executive with 25 years of experience in both operating and venture capital roles. She is the CEO of NeurAegis, Inc. as well as a member of its Board of Directors. Dr. Sung has been a "C-level" executive (CEO CBO) at multiple life science companies, including AEGEA Biotechnologies, Decoy Biosystems, ImmunoActiva, Tauriga Sciences, Avita Medical, PliCare Therapeutics and Cylene Pharmaceuticals. Dr. Sung received her Ph.D. in chemistry from Harvard University, where she was a National Science Foundation Predoctoral Fellow, and her B.S. in chemistry with a minor in English from Ohio State University, Phi Beta Kappa. Read More Read Less